Tag:
Leerink Swann
Latest Headlines
Latest Headlines
Radius $86M IPO to propel bone-growing injection drug, microneedle patch
Radius Health, which is testing injectable and microneedle patch versions of its lead osteoporosis drug, filed plans Feb. 6 to dive into the public markets. The IPO is ambitious for life sciences...
Leerink Swann recruiting new M&A experts
The life sciences bankers at Boston-based Leerink Swann & Co. say they plan to significantly boost their ranks this year as they shift from handling IPOs and follow-on financings to more mergers
